RSM: Urothelial cancer: advances, innovation and improving outcomes

Why attend?

• Hear from leading experts including Professor Param Mariappan, Professor Tom Powles, Professor Ben Challacombe and Professor Alison Birtle
• Explore how quality improvement initiatives, including lessons from Scotland's bladder cancer KPI programme, are shaping care delivery.
• Gain updates on bladder-sparing approaches for non-muscle-invasive and muscle-invasive bladder cancer
• Learn about emerging systemic therapies and advances in the management of metastatic urothelial cancer
• Examine current approaches to upper tract urothelial cancer, including nephron-sparing strategies and robotic surgery
• Explore disparities in bladder cancer outcomes and the impact of treatment on female patients.

Aims of the event

• Provide an update on contemporary management strategies for urothelial cancer
• Explore advances in diagnostics, surgery and systemic treatments across the bladder cancer pathway
• Support clinicians in applying emerging evidence and best practice to improve patient outcomes.

Learning outcomes

By attending this meeting, participants will be able to:

• Describe the key components of high-quality TURBT and their role in bladder cancer management
• Evaluate current bladder-sparing treatment options for non-muscle-invasive and muscle-invasive bladder cancer
• Assess recent developments in upper tract urothelial cancer management, including surgical and systemic approaches
• Apply learning from contemporary evidence and multidisciplinary discussion to improve patient care
• Recognise disparities in bladder cancer outcomes between male and female patients and consider strategies to improve counselling and care.

Who should attend?

This meeting is suitable for:

• Urologists and urology specialists
• Oncologists involved in the management of urothelial cancer
• Consultants, GPs, SAS doctors and resident doctors with an interest in urological oncology
• Clinical nurse specialists and allied health professionals involved in bladder cancer care
• Researchers and healthcare professionals with an interest in urothelial cancer and surgical innovation.